Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 1/2014

01-01-2014 | Research Article

Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis

Authors: Qiao-Hui Chen, Qing-Bing Wang, Bei Zhang

Published in: Tumor Biology | Issue 1/2014

Login to get access

Abstract

Common functional polymorphisms in the promoter region of microRNAs (miRNAs), based on multiple lines of evidence, might participate in transcriptional regulation and other biological processes, which interact to increase the risk of developing breast cancer. Since 2005, many studies have investigated the association between breast cancer risk and common single nucleotide polymorphisms (SNPs) in miRNAs. However, the findings of several meta-analyses are inconclusive or ambiguous. The aim of this Human Genome Epidemiology meta-analysis was to determine more precisely the relationship between common miRNA polymorphisms and breast cancer risk. Twelve case–control studies with a total of 7,170 breast cancer patients and 8,783 healthy controls were included. Eight SNPs in miRNA genes were examined. When all eligible studies were pooled in the meta-analysis, the miR-196a-2 rs11614913*T, miR-499 rs3746444*T, and miR-605 rs2043556*A alleles predicted a decreased risk of breast cancer among Asians, while not Caucasians. In addition, the miR-27a rs895919*C allele might be a protective factor for breast cancer among Caucasians. However, for the miR-146a rs2910164 (G>C), miR-149 rs2292832 (G>T), miR-373 rs12983273 (C>T), and miR-423 rs6505162 (C>A) polymorphisms, we failed to find any significant association with the risk of breast cancer in any genetic model. In conclusion, the current meta-analysis supports that the miR-196a-2 rs11614913*T, miR-499 rs3746444*T, miR-605 rs2043556*A, and miR-27a rs895919*C alleles might be protective factors for breast cancer.
Literature
1.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef
2.
McCormack VA, Boffetta P. Today’s lifestyles, tomorrow’s cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol. 2011;22:2349–57.PubMedCrossRef
3.
4.
Antoniou AC, Easton DF. Models of genetic susceptibility to breast cancer. Oncogene. 2006;25:5898–905.PubMedCrossRef
5.
Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 2008;124:31–42.PubMedCrossRef
6.
Evans JP, Skrzynia C, Susswein L, Harlan M. Genetics and the young woman with breast cancer. Breast Dis. 2005;23:17–29.PubMed
7.
Balmana J, Diez O, Rubio IT, Cardoso F. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol. 2011;22 Suppl 6:vi31–4.PubMed
8.
9.
He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–31.PubMedCrossRef
10.
Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102–14.PubMedCrossRef
11.
12.
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065–70.PubMedCrossRef
13.
Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature mir-125a alters the processing of pri-mirna. Hum Mol Genet. 2007;16:1124–31.PubMedCrossRef
14.
Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105:7269–74.PubMedCentralPubMedCrossRef
15.
Chen J, Tian W, Cai H, He H, Deng Y. (2012) Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol 29:2527–2534
16.
Toyama T, Kondo N, Endo Y, Sugiura H, Yoshimoto N, et al. High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. Jpn J Clin Oncol. 2012;42:256–63.PubMedCrossRef
17.
Wang C, Gao C, Zhuang JL, Ding C, Wang Y (2012) A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 138:2127–2136
18.
Zhao FL, Hu GD, Wang XF, Zhang XH, Zhang YK, et al. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer. J Int Med Res. 2012;40:859–66.PubMedCrossRef
19.
Zhou X, Marian C, Makambi KH, Kosti O, Kallakury BV, et al. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PloS One. 2012;7:e39011.PubMedCentralPubMedCrossRef
20.
Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740–4.PubMedCentralPubMedCrossRef
21.
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.PubMedCrossRef
22.
Esquela-Kerscher A, Slack FJ. OncomiRs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.PubMedCrossRef
23.
Qiu LX, He J, Wang MY, Zhang RX, Shi TY, et al. The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine. 2011;56:695–8.PubMedCrossRef
24.
Xu W, Xu J, Liu S, Chen B, Wang X, et al. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PloS One. 2011;6:e20471.PubMedCentralPubMedCrossRef
25.
Wang AX, Xu B, Tong N, Chen SQ, Yang Y, et al. Meta-analysis confirms that a common G/C variant in the pre-miR-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Gen Mol Res: GMR. 2012;11:3051–62.CrossRef
26.
Wang F, Sun G, Zou Y, Fan L, Song B. Lack of association of miR-146a rs2910164 polymorphism with gastrointestinal cancers: evidence from 10206 subjects. PloS One. 2012;7:e39623.PubMedCentralPubMedCrossRef
27.
Wang J, Bi J, Liu X, Li K, Di J, et al. Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case–control studies. Mol Biol Rep. 2012;39:4571–9.PubMedCrossRef
28.
Wang J, Wang Q, Liu H, Shao N, Tan B, et al. The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis. 2012;27:779–88.PubMedCrossRef
29.
Lian H, Wang L, Zhang J. Increased risk of breast cancer associated with cc genotype of has-miR-146a rs2910164 polymorphism in Europeans. PloS One. 2012;7:e31615.PubMedCentralPubMedCrossRef
30.
Wang F, Sun G, Zou Y, Li Y, Hao L, et al. Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PloS One. 2012;7:e45042.PubMedCentralPubMedCrossRef
31.
Wang L, Qian S, Zhi H, Zhang Y, Wang B, et al. The association between Hsa-miR-499t>c polymorphism and cancer risk: a meta-analysis. Gene. 2012;508:9–14.PubMedCrossRef
32.
Wang Y, Yang B, Ren X. Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case–control studies. Gene. 2012;509:267–72.PubMedCrossRef
33.
Qiu MT, Hu JW, Ding XX, Yang X, Zhang Z, et al. Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PloS One. 2012;7:e50887.PubMedCentralPubMedCrossRef
34.
35.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef
36.
Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123–37.PubMedCrossRef
37.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA : J Am Med Assoc. 2006;295:676–80.CrossRef
38.
Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, et al. MicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69:5970–7.PubMedCentralPubMedCrossRef
39.
Hu Z, Liang J, Wang Z, Tian T, Zhou X, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2009;30:79–84.PubMedCrossRef
40.
Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, et al. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. 2010;31:E1052–7.PubMedCrossRef
41.
Pastrello C, Polesel J, Della Puppa L, Viel A, Maestro R. Association between Hsa-miR-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis. 2010;31:2124–6.PubMedCrossRef
42.
Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat. 2010;121:693–702.PubMedCrossRef
43.
Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide polymorphism in Hsa-miR-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet Off J Int Soc Twin Stud. 2011;14:417–21.CrossRef
44.
Zhang P (2011) Polymorphisms of microRNA and ESR1 genes and their association with triple negative breast cancer risk and prognosis. Ph.D. thesis, Beijing Union Medical College
45.
Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PloS One. 2012;7:e30049.PubMedCentralPubMedCrossRef
46.
Catucci I, Verderio P, Pizzamiglio S, Bernard L, Dall’olio V, et al. The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat. 2012;133:805–7.PubMedCrossRef
47.
Linhares JJ, Azevedo Jr M, Siufi AA, de Carvalho CV, Wolgien MD, et al. Evaluation of single nucleotide polymorphisms in microRNAs (Hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer. BMC Med Genet. 2012;13:119.PubMedCentralPubMedCrossRef
48.
Smith RA, Jedlinski DJ, Gabrovska PN, Weinstein SR, Haupt L, et al. A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics. 2012;9:115–8.PubMed
49.
Zhang M, Jin M, Yu Y, Zhang S, Wu Y, et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care. 2012;21:274–80.CrossRef
50.
Chen T, Li Z, Yan J, Yang X, Salminen W. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Mutagenesis. 2012;27:59–66.PubMedCrossRef
51.
52.
Landi D, Gemignani F, Landi S. Role of variations within microRNA-binding sites in cancer. Mutagenesis. 2012;27:205–10.PubMedCrossRef
53.
54.
Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, et al. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women’s Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Breast Cancer Res. 2011;13:R114.PubMedCentralPubMedCrossRef
55.
Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007;67:2456–68.PubMedCrossRef
56.
Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673–7.PubMedCrossRef
57.
Chu H, Wang M, Shi D, Ma L, Zhang Z, et al. Hsa-miR-196a2 rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case–control studies. PloS One. 2011;6:e18108.PubMedCentralPubMedCrossRef
58.
Gao LB, Bai P, Pan XM, Jia J, Li LJ, et al. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2011;125:571–4.PubMedCrossRef
59.
Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, et al. Mir-196a2c allele is a low-penetrant risk factor for cancer development. Cytokine. 2011;56:589–92.PubMedCrossRef
60.
Tian T, Xu Y, Dai J, Wu J, Shen H, et al. Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int J Mol Epidemiol Genet. 2010;1:358–66.PubMedCentralPubMed
61.
Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, et al. A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:269–75.PubMedCrossRef
62.
Garcia AI, Cox DG, Barjhoux L, Verny-Pierre C, Barnes D, et al (2011) The rs2910164:G>c snp in the mir146a gene is not associated with breast cancer risk in brca1 and brca2 mutation carriers. Human Mutat 32:1004–1007
63.
Zhong S, Chen Z, Xu J, Li W, Zhao J (2013) Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep 40:3181–3186
64.
Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007;67:11001–11.PubMedCrossRef
65.
Guttilla IK, White BA. Coordinate regulation of foxo1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009;284:23204–16.PubMedCrossRef
66.
Ma Y, Yu S, Zhao W, Lu Z, Chen J. MiR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting sprouty2. Cancer Lett. 2010;298:150–8.PubMedCrossRef
67.
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–42.PubMedCrossRef
Metadata
Title
Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis
Authors
Qiao-Hui Chen
Qing-Bing Wang
Bei Zhang
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 1/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1074-7

Other articles of this Issue 1/2014

Tumor Biology 1/2014 Go to the issue

Research Article

The phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancer

Research Article

RETRACTED ARTICLE: Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis

Research Article

Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway

Research Article

Thrombomodulin mediates the migration of cervical cancer cells through the regulation of epithelial–mesenchymal transition biomarkers

Research Article

Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis

Research Article

Association of rs2233678 and rs2233679 polymorphisms in the PIN1 gene with cancer risk: a meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits